(IN BRIEF) Airbus SE has provided an update on its share buyback transactions, which are carried out in accordance with Regulation (EU) No 596/2014 of the European Parliament and the Council. These transactions are part of a share buyback program … Read the full press release
(IN BRIEF) On December 20, 2023, Outokumpu has successfully concluded its share repurchases as part of its buyback program. The buyback program, announced on November 29, 2023, allowed the company to repurchase up to 11 million shares with a maximum … Read the full press release
Posted in Business, Economy, Financial, Finland, Industrial, Investment, Management, Media, News
Tagged buyback program, Financial, investment, Outokumpu
(IN BRIEF) Three, the largest mobile network in Ireland, is pioneering 5G Standalone technology, making it the first Irish operator to do so. This innovative technology, powered by Ericsson, enables businesses to harness the full potential of 5G with a … Read the full press release
Posted in Business, Environment, Financial, Government, Industrial, Infrastructure & Utilities, Investment, Ireland, Management, News, Sweden, Technology, Telecom
Tagged 5G standalone, businesses, connectivity, David Hennessy, Dr. Enda Fallon, Ericsson, Ireland, John Griffin, partnership, sustainability, Three
(IN BRIEF) Orange Spain and Ericsson are embarking on a historic partnership to introduce private 5G networks for the B2B sector in Spain. This groundbreaking collaboration aims to empower businesses to deploy their own private 5G networks, offering real-time automation, … Read the full press release
Posted in Business, Economy, Environment, Financial, Government, Industrial, Infrastructure & Utilities, Investment, Management, News, Spain, Sweden, Technology, Telecom
Tagged 5G networks, Ericsson, Luisa Muñoz, Mónica Sala, Orange Spain, partnership, Spain, sustainability
(IN BRIEF) Sanofi has announced the discontinuation of the global clinical development program for tusamitamab ravtansine, following an interim analysis of the Phase 3 CARMEN-LC03 trial. The trial assessed tusamitamab ravtansine as a monotherapy in previously treated metastatic non-squamous non-small … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Dietmar Berger, NSCLC, Sanofi, Tusamitamab Ravtansine
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?